Immunization of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank African swine fever virus immunogenic and protective proteins

James K. Jancovich, Dave Chapman, Debra Hansen, Mark D. Robida, Andrey Loskutov, Felicia Craciunescu, Alex Borovkov, Karen Kibler, Lynnette Goatley, Katherine King, Christopher L. Netherton, Geraldine Taylor, Bertram Jacobs, Kathryn Sykes, Linda K. Dixon

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

African swine fever virus (ASFV) causes an acute hemorrhagic fever in domestic pigs, with high socioeconomic impact. No vaccine is available, limiting options for control. Although live attenuated ASFV can induce up to 100% protection against lethal challenge, little is known of the antigens which induce this protective response. To identify additional ASFV immunogenic and potentially protective antigens, we cloned 47 viral genes in individual plasmids for gene vaccination and in recombinant vaccinia viruses. These antigens were selected to include proteins with different functions and timing of expression. Pools of up to 22 antigens were delivered by DNA prime and recombinant vaccinia virus boost to groups of pigs. Responses of immune lymphocytes from pigs to individual recombinant proteins and to ASFV were measured by interferon gamma enzyme-linked immunosorbent spot (ELISpot) assays to identify a subset of the antigens that consistently induced the highest responses. All 47 antigens were then delivered to pigs by DNA prime and recombinant vaccinia virus boost, and pigs were challenged with a lethal dose of ASFV isolate Georgia 2007/1. Although pigs developed clinical and pathological signs consistent with acute ASFV, viral genome levels were significantly reduced in blood and several lymph tissues in those pigs immunized with vectors expressing ASFV antigens compared with the levels in control pigs.

Original languageEnglish (US)
Article numbere02219-17
JournalJournal of Virology
Volume92
Issue number8
DOIs
StatePublished - Apr 1 2018

Fingerprint

African Swine Fever Virus
African swine fever virus
Vaccinia virus
Recombinant DNA
Immunization
immunization
Swine
Antigens
swine
antigens
DNA
Proteins
proteins
Sus scrofa
Viral Genes
Viral Genome
Lymph
lymph
Recombinant Proteins
lethal dose

Keywords

  • African swine fever virus
  • DNA vaccines
  • Immune markers
  • Vaccinia virus
  • Veterinary vaccine development

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

Immunization of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank African swine fever virus immunogenic and protective proteins. / Jancovich, James K.; Chapman, Dave; Hansen, Debra; Robida, Mark D.; Loskutov, Andrey; Craciunescu, Felicia; Borovkov, Alex; Kibler, Karen; Goatley, Lynnette; King, Katherine; Netherton, Christopher L.; Taylor, Geraldine; Jacobs, Bertram; Sykes, Kathryn; Dixon, Linda K.

In: Journal of Virology, Vol. 92, No. 8, e02219-17, 01.04.2018.

Research output: Contribution to journalArticle

Jancovich, JK, Chapman, D, Hansen, D, Robida, MD, Loskutov, A, Craciunescu, F, Borovkov, A, Kibler, K, Goatley, L, King, K, Netherton, CL, Taylor, G, Jacobs, B, Sykes, K & Dixon, LK 2018, 'Immunization of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank African swine fever virus immunogenic and protective proteins', Journal of Virology, vol. 92, no. 8, e02219-17. https://doi.org/10.1128/JVI.02219-17
Jancovich, James K. ; Chapman, Dave ; Hansen, Debra ; Robida, Mark D. ; Loskutov, Andrey ; Craciunescu, Felicia ; Borovkov, Alex ; Kibler, Karen ; Goatley, Lynnette ; King, Katherine ; Netherton, Christopher L. ; Taylor, Geraldine ; Jacobs, Bertram ; Sykes, Kathryn ; Dixon, Linda K. / Immunization of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank African swine fever virus immunogenic and protective proteins. In: Journal of Virology. 2018 ; Vol. 92, No. 8.
@article{18279257848f4e1498d3ae36f8e49185,
title = "Immunization of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank African swine fever virus immunogenic and protective proteins",
abstract = "African swine fever virus (ASFV) causes an acute hemorrhagic fever in domestic pigs, with high socioeconomic impact. No vaccine is available, limiting options for control. Although live attenuated ASFV can induce up to 100{\%} protection against lethal challenge, little is known of the antigens which induce this protective response. To identify additional ASFV immunogenic and potentially protective antigens, we cloned 47 viral genes in individual plasmids for gene vaccination and in recombinant vaccinia viruses. These antigens were selected to include proteins with different functions and timing of expression. Pools of up to 22 antigens were delivered by DNA prime and recombinant vaccinia virus boost to groups of pigs. Responses of immune lymphocytes from pigs to individual recombinant proteins and to ASFV were measured by interferon gamma enzyme-linked immunosorbent spot (ELISpot) assays to identify a subset of the antigens that consistently induced the highest responses. All 47 antigens were then delivered to pigs by DNA prime and recombinant vaccinia virus boost, and pigs were challenged with a lethal dose of ASFV isolate Georgia 2007/1. Although pigs developed clinical and pathological signs consistent with acute ASFV, viral genome levels were significantly reduced in blood and several lymph tissues in those pigs immunized with vectors expressing ASFV antigens compared with the levels in control pigs.",
keywords = "African swine fever virus, DNA vaccines, Immune markers, Vaccinia virus, Veterinary vaccine development",
author = "Jancovich, {James K.} and Dave Chapman and Debra Hansen and Robida, {Mark D.} and Andrey Loskutov and Felicia Craciunescu and Alex Borovkov and Karen Kibler and Lynnette Goatley and Katherine King and Netherton, {Christopher L.} and Geraldine Taylor and Bertram Jacobs and Kathryn Sykes and Dixon, {Linda K.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1128/JVI.02219-17",
language = "English (US)",
volume = "92",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "8",

}

TY - JOUR

T1 - Immunization of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank African swine fever virus immunogenic and protective proteins

AU - Jancovich, James K.

AU - Chapman, Dave

AU - Hansen, Debra

AU - Robida, Mark D.

AU - Loskutov, Andrey

AU - Craciunescu, Felicia

AU - Borovkov, Alex

AU - Kibler, Karen

AU - Goatley, Lynnette

AU - King, Katherine

AU - Netherton, Christopher L.

AU - Taylor, Geraldine

AU - Jacobs, Bertram

AU - Sykes, Kathryn

AU - Dixon, Linda K.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - African swine fever virus (ASFV) causes an acute hemorrhagic fever in domestic pigs, with high socioeconomic impact. No vaccine is available, limiting options for control. Although live attenuated ASFV can induce up to 100% protection against lethal challenge, little is known of the antigens which induce this protective response. To identify additional ASFV immunogenic and potentially protective antigens, we cloned 47 viral genes in individual plasmids for gene vaccination and in recombinant vaccinia viruses. These antigens were selected to include proteins with different functions and timing of expression. Pools of up to 22 antigens were delivered by DNA prime and recombinant vaccinia virus boost to groups of pigs. Responses of immune lymphocytes from pigs to individual recombinant proteins and to ASFV were measured by interferon gamma enzyme-linked immunosorbent spot (ELISpot) assays to identify a subset of the antigens that consistently induced the highest responses. All 47 antigens were then delivered to pigs by DNA prime and recombinant vaccinia virus boost, and pigs were challenged with a lethal dose of ASFV isolate Georgia 2007/1. Although pigs developed clinical and pathological signs consistent with acute ASFV, viral genome levels were significantly reduced in blood and several lymph tissues in those pigs immunized with vectors expressing ASFV antigens compared with the levels in control pigs.

AB - African swine fever virus (ASFV) causes an acute hemorrhagic fever in domestic pigs, with high socioeconomic impact. No vaccine is available, limiting options for control. Although live attenuated ASFV can induce up to 100% protection against lethal challenge, little is known of the antigens which induce this protective response. To identify additional ASFV immunogenic and potentially protective antigens, we cloned 47 viral genes in individual plasmids for gene vaccination and in recombinant vaccinia viruses. These antigens were selected to include proteins with different functions and timing of expression. Pools of up to 22 antigens were delivered by DNA prime and recombinant vaccinia virus boost to groups of pigs. Responses of immune lymphocytes from pigs to individual recombinant proteins and to ASFV were measured by interferon gamma enzyme-linked immunosorbent spot (ELISpot) assays to identify a subset of the antigens that consistently induced the highest responses. All 47 antigens were then delivered to pigs by DNA prime and recombinant vaccinia virus boost, and pigs were challenged with a lethal dose of ASFV isolate Georgia 2007/1. Although pigs developed clinical and pathological signs consistent with acute ASFV, viral genome levels were significantly reduced in blood and several lymph tissues in those pigs immunized with vectors expressing ASFV antigens compared with the levels in control pigs.

KW - African swine fever virus

KW - DNA vaccines

KW - Immune markers

KW - Vaccinia virus

KW - Veterinary vaccine development

UR - http://www.scopus.com/inward/record.url?scp=85044644981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044644981&partnerID=8YFLogxK

U2 - 10.1128/JVI.02219-17

DO - 10.1128/JVI.02219-17

M3 - Article

VL - 92

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 8

M1 - e02219-17

ER -